Stay updated on XmAb®20717 in Selected Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the XmAb®20717 in Selected Solid Tumors Clinical Trial page.

Latest updates to the XmAb®20717 in Selected Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedA site-wide NIH banner announces website transition updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” under Executive Order 14434.SummaryDifference0.6%

- Check9 days agoChange DetectedThe footer’s ClinicalTrials.gov site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check16 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check37 days agoChange DetectedA new revision entry v3.7.0 was added to the history, and the prior revision v3.6.6 was removed.SummaryDifference0.1%

- Check58 days agoChange DetectedA new revision tag v3.6.6 was added to the study history, replacing the previous v3.6.5. This reflects a small update to the page's metadata in the record history.SummaryDifference0.1%

- Check79 days agoChange DetectedA new page revision (v3.6.5) was added to the record history, while the previous revision (v3.6.4) was removed, indicating a version update to the study's history.SummaryDifference0.1%

Stay in the know with updates to XmAb®20717 in Selected Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb®20717 in Selected Solid Tumors Clinical Trial page.